76 related articles for article (PubMed ID: 32411179)
1. PKMYT1 as a Potential Target to Improve the Radiosensitivity of Lung Adenocarcinoma.
Long HP; Liu JQ; Yu YY; Qiao Q; Li G
Front Genet; 2020; 11():376. PubMed ID: 32411179
[TBL] [Abstract][Full Text] [Related]
2. Transcription factor E2F7 activates PKMYT1 to partially suppress adriamycin sensitivity in gastric cancer through the MAPK signaling pathway.
Yang X; Zeng J; Jiang C; Zhang Y; Zhang X
Rev Invest Clin; 2024 Mar; 76(1):6-17. PubMed ID: 38253021
[TBL] [Abstract][Full Text] [Related]
3. Overexpression of PKMYT1 Facilitates Tumor Development and Is Correlated with Poor Prognosis in Clear Cell Renal Cell Carcinoma.
Chen P; Zhang Z; Chen X
Med Sci Monit; 2020 Oct; 26():e926755. PubMed ID: 33024069
[TBL] [Abstract][Full Text] [Related]
4. PKMYT1 aggravates the progression of ovarian cancer by targeting SIRT3.
Xuan ZH; Wang HP; Zhang XN; Chen ZX; Zhang HY; Gu MM
Eur Rev Med Pharmacol Sci; 2020 May; 24(10):5259-5266. PubMed ID: 32495859
[TBL] [Abstract][Full Text] [Related]
5. PKMYT1 Promotes Gastric Cancer Cell Proliferation and Apoptosis Resistance.
Zhang QY; Chen XQ; Liu XC; Wu DM
Onco Targets Ther; 2020; 13():7747-7757. PubMed ID: 32801781
[TBL] [Abstract][Full Text] [Related]
6. A WEE1 family business: regulation of mitosis, cancer progression, and therapeutic target.
Ghelli Luserna di Rorà A; Cerchione C; Martinelli G; Simonetti G
J Hematol Oncol; 2020 Sep; 13(1):126. PubMed ID: 32958072
[TBL] [Abstract][Full Text] [Related]
7. Identification of critical genes in gastric cancer to predict prognosis using bioinformatics analysis methods.
Liu J; Ma L; Chen Z; Song Y; Gu T; Liu X; Zhao H; Yao N
Ann Transl Med; 2020 Jul; 8(14):884. PubMed ID: 32793728
[TBL] [Abstract][Full Text] [Related]
8. MELK is an oncogenic kinase essential for metastasis, mitotic progression, and programmed death in lung carcinoma.
Tang Q; Li W; Zheng X; Ren L; Liu J; Li S; Wang J; Du G
Signal Transduct Target Ther; 2020 Dec; 5(1):279. PubMed ID: 33262323
[TBL] [Abstract][Full Text] [Related]
9. Expression signature, prognosis value, and immune characteristics of Siglec-15 identified by pan-cancer analysis.
Li B; Zhang B; Wang X; Zeng Z; Huang Z; Zhang L; Wei F; Ren X; Yang L
Oncoimmunology; 2020 Aug; 9(1):1807291. PubMed ID: 32939323
[TBL] [Abstract][Full Text] [Related]
10. Development and validation of an immune-related prognostic signature in lung adenocarcinoma.
Sun S; Guo W; Wang Z; Wang X; Zhang G; Zhang H; Li R; Gao Y; Qiu B; Tan F; Gao Y; Xue Q; Gao S; He J
Cancer Med; 2020 Aug; 9(16):5960-5975. PubMed ID: 32592319
[TBL] [Abstract][Full Text] [Related]
11. SKA1/2/3 serves as a biomarker for poor prognosis in human lung adenocarcinoma.
Chen C; Guo Q; Song Y; Xu G; Liu L
Transl Lung Cancer Res; 2020 Apr; 9(2):218-231. PubMed ID: 32420061
[TBL] [Abstract][Full Text] [Related]
12. BICC1 as a novel prognostic biomarker in gastric cancer correlating with immune infiltrates.
Zhao R; Peng C; Song C; Zhao Q; Rong J; Wang H; Ding W; Wang F; Xie Y
Int Immunopharmacol; 2020 Oct; 87():106828. PubMed ID: 32736193
[TBL] [Abstract][Full Text] [Related]
13. Integrated Analysis of lncRNA-Mediated ceRNA Network in Lung Adenocarcinoma.
Wu X; Sui Z; Zhang H; Wang Y; Yu Z
Front Oncol; 2020; 10():554759. PubMed ID: 33042838
[TBL] [Abstract][Full Text] [Related]
14. Independent prognostic implications of
Ma C; Luo H; Cao J; Gao C; Fa X; Wang G
J Cancer; 2020; 11(23):7009-7022. PubMed ID: 33123291
[No Abstract] [Full Text] [Related]
15. Identification of key genes and biological pathways in lung adenocarcinoma via bioinformatics analysis.
Wang Y; Zhou Z; Chen L; Li Y; Zhou Z; Chu X
Mol Cell Biochem; 2021 Feb; 476(2):931-939. PubMed ID: 33130972
[TBL] [Abstract][Full Text] [Related]
16. High expression of RRM2 as an independent predictive factor of poor prognosis in patients with lung adenocarcinoma.
Jin CY; Du L; Nuerlan AH; Wang XL; Yang YW; Guo R
Aging (Albany NY); 2020 Dec; 13(3):3518-3535. PubMed ID: 33411689
[TBL] [Abstract][Full Text] [Related]
17. Identification of a novel gene expression signature associated with overall survival in patients with lung adenocarcinoma: A comprehensive analysis based on TCGA and GEO databases.
Zhao J; Guo C; Ma Z; Liu H; Yang C; Li S
Lung Cancer; 2020 Nov; 149():90-96. PubMed ID: 33002836
[TBL] [Abstract][Full Text] [Related]
18. Identification of crucial genes associated with lung adenocarcinoma by bioinformatic analysis.
Dai JJ; Zhou WB; Wang B
Medicine (Baltimore); 2020 Oct; 99(44):e23052. PubMed ID: 33126397
[TBL] [Abstract][Full Text] [Related]
19. The value of CEP55 gene as a diagnostic biomarker and independent prognostic factor in LUAD and LUSC.
Fu L; Wang H; Wei D; Wang B; Zhang C; Zhu T; Ma Z; Li Z; Wu Y; Yu G
PLoS One; 2020; 15(5):e0233283. PubMed ID: 32437446
[TBL] [Abstract][Full Text] [Related]
20. Stemness Related Genes Revealed by Network Analysis Associated With Tumor Immune Microenvironment and the Clinical Outcome in Lung Adenocarcinoma.
Zeng H; Ji J; Song X; Huang Y; Li H; Huang J; Ma X
Front Genet; 2020; 11():549213. PubMed ID: 33193623
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
